Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage
Geographical Focus
Belgium
Industries Focus
- Software
- HealthTech
- Biotech
- DeepTech
Investment Size:
500,000 to 8,850,000 USD
Investor Details Founded: 2012
Qbic Fund is a sector-agnostic seed and early-stage venture capital fund focusing on creating impact through technological breakthroughs. The fund supports spin-offs and start-ups that valorize research from its knowledge partners, typically participating in the first external investment round and continuing to support these companies throughout their growth. Qbic Fund has raised three funds: Qbic I in 2012 with €40 million, Qbic II in 2017 with nearly €60 million, and Qbic III in 2022 with €88.5 million. The fund collaborates with a network of Belgian universities, research institutes, and hospitals, including Ghent University, Vrije Universiteit Brussel (VUB), University of Antwerp, University of Liège, imec, VITO, and several university hospitals. Qbic Fund's portfolio includes companies across various sectors, such as Spica Therapeutics, AILOS Robotics, Animab, Pleevi, Swave, Tanai Therapeutics, VoxelSensors, eyeo, Rainbow Crops, moveUP, Aloxy, MRM Health, Blue Foot, Trince, AmphiStar, and Flindr. The fund's investment strategy is to support companies that are spin-offs from its knowledge partners or have strong R&D collaborations with them, aiming to transform technological innovations into sustainable businesses. Qbic Fund is one of the largest inter-university spin-off funds in Europe, managing nearly €190 million across its funds. The fund's mission is to create impact through the transformation of technological breakthroughs into sustainable business. Qbic Fund is based in Belgium and operates primarily within the country, focusing on sectors such as Biotech, HealthTech, DeepTech, and Software. The fund's investment approach is to participate in the first external investment round of a company and continue to support and fund these companies throughout their growth. Qbic Fund is managed by an independent team of seasoned investment professionals and has a strong network of knowledge partners, including universities, research institutes, and hospitals in Belgium. The fund's portfolio includes a diverse range of companies across various sectors, demonstrating its commitment to supporting innovative ventures with high growth potential. Qbic Fund's investment strategy is to support companies that valorize research from its knowledge partners, aiming to create impact through technological breakthroughs and sustainable business development. The fund's mission is to transform technological innovations into successful businesses, contributing to the growth and development of the Belgian economy. Qbic Fund is one of the largest inter-university spin-off funds in Europe, managing nearly €190 million across its funds, and continues to support and invest in innovative companies throughout their growth stages.
Requirements
- Spin-offs from knowledge partners
- Start-ups with strong R&D collaborations with knowledge partners
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Spica Therapeutics
- AILOS Robotics
- Animab
- Pleevi
- Swave
- Tanai Therapeutics
- VoxelSensors
- Eyeo
- Rainbow Crops
- moveUP
- Aloxy
- MRM Health
- Blue Foot
- Trince
- AmphiStar
- Flindr
Mentioned In
-
$24.95
-
$19.95
-
$49.95
-
$99.00
Claim this Investor
Are you an official representative of Qbic Fund?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim